| FMCCX | FSMAX | FMCCX / FSMAX | |
| Total Expense Ratio | 0.68 | 0.04 | 1,943% |
| Annual Report Gross Expense Ratio | 0.68 | 0.04 | 1,943% |
| Fund Existence | 30 years | 14 years | - |
| Gain YTD | 4.778 | 6.492 | 74% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.16B | 41.5B | 5% |
| Annual Yield % from dividends | 0.48 | 0.43 | 111% |
| Returns for 1 year | -0.77 | 3.62 | -21% |
| Returns for 3 years | 21.95 | 49.92 | 44% |
| Returns for 5 years | 23.13 | 33.53 | 69% |
| Returns for 10 years | 47.12 | 94.09 | 50% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DTCAX | 20.51 | 0.08 | +0.39% |
| BNY Mellon Sust US Equity A | |||
| UOPSX | 93.08 | N/A | N/A |
| ProFunds UltraNASDAQ-100 Svc | |||
| MSVDX | 6.33 | N/A | N/A |
| Morgan Stanley Vitality Portfolio I | |||
| CBGAX | 15.01 | N/A | N/A |
| ClearBridge Global Infrastructure Inc C | |||
| JFNIX | 81.94 | -0.17 | -0.21% |
| Janus Henderson Global Life Sciences I | |||